It has been found that the capacity of T cells to kill tumors is determined by the anti-cancer “base” for stem cell-like CD8+ T cell formation, and is not due to many exhausted T cells with positive checkpoints or high expression levels of PD-L1 in the tumor (Jansen et al., 2019). Here, CD8A is linked to neoplasm.